Wednesday 13 December 2017
Contact US    |    Archive
PR
3 months ago

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

MARLBOROUGH, Mass., Sept. 25, 2017 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has launched the Re

Read on the original site


Hashtags:   

Boston

 | 

Scientific

 | 

Announces

 | 

FDA

 | 

Approval

 | 

for

 | 

MRI

 | 

Labeling

 | 

High

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries